These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 2012752

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A phase I/II study of sequential interleukin-3 and granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromes.
    Nand S, Sosman J, Godwin JE, Fisher RI.
    Blood; 1994 Jan 15; 83(2):357-60. PubMed ID: 8286736
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.
    Kasper C, Zahner J, Sayer HG.
    J Cancer Res Clin Oncol; 2002 Sep 15; 128(9):497-502. PubMed ID: 12242514
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II study.
    Höffken K, Overkamp F, Stirbu J, Grothey A, Flasshove M, Hoelzer D, Ganser A.
    Onkologie; 1990 Feb 15; 13(1):33-7. PubMed ID: 2186322
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Recombinant human GM-CSF in small cell lung cancer: a phase I/II study.
    Anderson H, Gurney H, Thatcher N, Swindell R, Scarffe JH, Weiner J.
    Recent Results Cancer Res; 1991 Feb 15; 121():155-61. PubMed ID: 1650015
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Treatment with very low-dose GM-CSF in myelodysplastic syndromes with neutropenia. A report on 28 cases.
    Rose C, Wattel E, Bastion Y, Berger E, Bauters F, Coiffier B, Fenaux P.
    Leukemia; 1994 Sep 15; 8(9):1458-62. PubMed ID: 8090025
    [Abstract] [Full Text] [Related]

  • 40. Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study.
    Steward WP, Scarffe JH, Austin R, Bonnem E, Thatcher N, Morgenstern G, Crowther D.
    Br J Cancer; 1989 Jan 15; 59(1):142-5. PubMed ID: 2667607
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.